The coverage group at CMS is closely examining genetic testing for cancer, with three agency-commissioned technology assessments on the topic released last week. Two of them will inform an upcoming Medicare Evidence Development and Coverage Advisory Committee meeting.
The assessments come not long after CMS included genetic testing on its latest list of possible national coverage determination topics
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?